HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYNEndocrinology NetworkPractical CardiologyRheumatology Netowrk

Alexandra Ward, MA

Alexandra Ward, MA, is vice president of content at MJH Life Sciences. She attended Rider University and earned a degree in journalism before pursing a masters in magazine writing from New York University. Prior to making a switch to health care news in 2018, Allie spent 6 years in New York City working in political journalism. She enjoys cooking, biking, and her dog Bo. Follow her on Twitter at @allie_ward or email her at [email protected]


Mesenchymal Stem Cell Therapy an Option for Patients With Type 2 Diabetes Complications

May 17, 2022

Investigators in Ukraine share data on the safety and efficacy of autologous mesenchymal stem cell administration for type 2 diabetes complications under the hypothesis that success is dependent on the administration route and quality of the autologous MSC population.

Early Momentum for a Genomic Approach to Sickle Cell Disease Therapy

May 17, 2022

In a late-breaking presentation at ASGCT 2022, investigators shared preclinical results of a gene-editing strategy that seeks to reactivate developmentally silenced fetal hemoglobin (HbF, α2γ2) in order to replace defective sickle hemoglobin (HbS, α2βS2).